Since METTL3-mediated m6A modification could enhance PD-L1 mRNA stability through the METTL3-IGF2BP3 axis, tumor immune cell infiltrations and CD8+ T cell functions were enhanced forcefully when METTL3 or IGF2BP3 is inhibited. The gene discussed is IGF2BP3; the disease is neoplasm.